JNJ
Moving with its group (XLV +2.4%)
- JNJ +2.12% on the last session vs SPY −0.25%: +2.4 pts of stock-specific move.
- Reported 3Q2026 Oct 13 before the open: EPS $2.59 vs $2.52 expected (beat, +$0.07, +2.7%); revenue $25.4B (+0.1% in line). The stock moved -5.7% on Tue's session (-5.7 pts vs SPY).
- The health care ETF (XLV) +2.4% (+2.7 pts vs SPY): the stock moved with its group.
- Aftermath, big gain (+2.1% today so far, past its big-gain line of +1.5%): After its 61 big gains in the past 5 years, JNJ was higher a week later 36 times out of 61; half the outcomes fell between -1.0% and +2.3%. History, not a forecast.
- 3 analyst actions in the past 10 days (2 positive, 0 negative); latest: RBC Capital maintained Outperform, raised target $287 → $290.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
- Activity: volume on pace for 1.8× its 20-day average.
Insiders
Officers, directors and 10% owners file SEC Form 4 within two business days. Unplanned: the insider chose to trade now, the trades worth attention; their dollars make the net above. 10b5-1 plan: scheduled in advance, kept for the record. Tax: shares withheld on vesting stock, not a market trade. Awards, option exercises and gifts are left out. Source: SEC EDGAR, collected daily for the stocks discussed on Reddit.
Congress
| Trade date | Member | Chamber | Side | Amount | Disclosed |
|---|---|---|---|---|---|
| Sep 8, 2026 | Lloyd Doggett | House | Buy | $1K–$15K | Oct 5 |
| Aug 27, 2026 | Thomas H. Kean | House | Sell | $1K–$15K | Sep 12 |
| Aug 20, 2026 | John Boozman | Senate | Sell | $1K–$15K | Sep 11 |
| Jul 30, 2026 | Richard Dean McCormick | House | Sell | $1K–$15K | Aug 14 |
| Jun 29, 2026 | Thomas H. Kean | House | Sell | $1K–$15K | Jul 15 |
| Jun 9, 2026 | Lloyd Doggett | House | Buy | $1K–$15K | Jul 6 |
| Jun 2, 2026 | Thomas H. Kean | House | Sell | $1K–$15K | Jul 15 |
| Mar 30, 2026 | Alan Armstrong | Senate | Buy | $1K–$15K | Jul 21 |
| Mar 27, 2026 | Alan Armstrong | Senate | Buy | $15K–$50K | Jul 21 |
| Mar 26, 2026 | Thomas H. Kean | House | Sell | $1K–$15K | Apr 13 |
| Mar 19, 2026 | Richard Dean McCormick | House | Sell | $1K–$15K | Apr 7 |
| Mar 19, 2026 | Richard Dean McCormick | House | Sell | $1K–$15K | Apr 7 |
| Mar 19, 2026 | John Boozman | Senate | Sell | $1K–$15K | Apr 14 |
| Mar 10, 2026 | Lloyd Doggett | House | Buy | $1K–$15K | Apr 6 |
| Jan 23, 2026 | Thomas H. Kean | House | Sell | $15K–$50K | Feb 19 |
| Dec 18, 2025 | Julie Johnson | House | Sell | $1K–$15K | Jan 15 |
| Dec 9, 2025 | Lloyd Doggett | House | Buy | $1K–$15K | Jan 2 |
| Nov 20, 2025 | Thomas H. Kean | House | Sell | $15K–$50K | Dec 19 |
| Nov 13, 2025 | Julie Johnson | House | Sell | $1K–$15K | Dec 11 |
| Nov 5, 2025 | Richard Dean McCormick | House | Buy | $1K–$15K | Dec 9 |
| Oct 31, 2025 | Lisa McClain | House | Sell | $1K–$15K | Nov 21 |
| Oct 30, 2025 | Lisa McClain | House | Buy | $1K–$15K | Nov 21 |
| Oct 30, 2025 | Lisa McClain | House | Sell | $1K–$15K | Nov 21 |
| Oct 10, 2025 | Jared Moskowitz | House | Sell | $1K–$15K | Nov 22 |
| Oct 10, 2025 | Jared Moskowitz | House | Sell | $1K–$15K | Nov 22 |
| Sep 23, 2025 | Valerie Hoyle | House | Sell | $1K–$15K | Oct 10 |
Members of Congress report trades within 45 days of the trade date, so these are never real-time. Amounts are disclosed as ranges; the net uses each range's midpoint (≈). Source: House and Senate periodic transaction reports via CongressInvests, refreshed daily.
Funds
| Investor | Shares | Value | Of its portfolio | Vs quarter before | As of |
|---|---|---|---|---|---|
| Bridgewater (Ray Dalio's firm) | 669,135 | $169.9M | 0.70% | -4% | Q2 2026 |
| Soros Fund Management (George Soros) | 34,019 | $8.6M | 0.14% | -2% | Q2 2026 |
| Date | Investor | Move | Source | Shares | ≈ Value | Now held | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | Bridgewater (Ray Dalio's firm) | Trimmed | 13F, Q1 2026 | 617,074 | $150.8M | 0.8% | May 15 |
| Feb 13, 2026 | Bridgewater (Ray Dalio's firm) | Trimmed | 13F, Q4 2025 | 401,819 | $83.2M | 1.0% | Feb 13 |
| Nov 13, 2025 | Bridgewater (Ray Dalio's firm) | Trimmed | 13F, Q3 2025 | 566,762 | $105.1M | 1.2% | Nov 13 |
Well-known investors we follow (Buffett, Ackman, Icahn, Druckenmiller, Tepper, Soros and others). 13F: managers report their US stock holdings up to 45 days after each quarter; the change from the quarter before is dated by the filing, the trades happened some time in the quarter, and the value is at the quarter-end price (≈). New and closed positions, and adds or cuts of 20% or more, of positions at least 0.2% of the portfolio. ARK: Cathie Wood's ETFs publish their holdings every morning; the change beyond the fund's own inflows and outflows, dated by the session it traded. 5%+ stake: Schedule 13D (with intent to influence) or 13G (passive), filed within days. Source: SEC EDGAR, ark-funds.com, refreshed daily. Who holds it: each investor's latest 13F portfolio (positions at the quarter's end; one sold since would not show until the next filing), and ARK's ETFs as of their latest daily file. The funds we follow and their portfolios · All recent insider, congressional and fund moves